These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31407404)
21. Dysregulated microRNAs involved in the progression of cervical neoplasm. Zeng K; Zheng W; Mo X; Liu F; Li M; Liu Z; Zhang W; Hu X Arch Gynecol Obstet; 2015 Oct; 292(4):905-13. PubMed ID: 25851497 [TBL] [Abstract][Full Text] [Related]
22. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer. Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025 [TBL] [Abstract][Full Text] [Related]
23. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
24. Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer. Shukla V; Varghese VK; Kabekkodu SP; Mallya S; Chakrabarty S; Jayaram P; Pandey D; Banerjee S; Sharan K; Satyamoorthy K Gynecol Oncol; 2019 Oct; 155(1):135-143. PubMed ID: 31434614 [TBL] [Abstract][Full Text] [Related]
25. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia. Kawai S; Fujii T; Kukimoto I; Yamada H; Yamamoto N; Kuroda M; Otani S; Ichikawa R; Nishio E; Torii Y; Iwata A Sci Rep; 2018 May; 8(1):7070. PubMed ID: 29728572 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Liu SS; Chan KKL; Chu DKH; Wei TN; Lau LSK; Ngu SF; Chu MMY; Tse KY; Ip PPC; Ng EKO; Cheung ANY; Ngan HYS Mol Oncol; 2018 Dec; 12(12):2009-2022. PubMed ID: 30221475 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer. Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645 [TBL] [Abstract][Full Text] [Related]
28. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer. Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867 [TBL] [Abstract][Full Text] [Related]
29. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer. Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676 [TBL] [Abstract][Full Text] [Related]
30. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
31. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer. Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379 [TBL] [Abstract][Full Text] [Related]
32. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Zhao S; Yao D; Chen J; Ding N Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812 [TBL] [Abstract][Full Text] [Related]
33. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer. Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176 [TBL] [Abstract][Full Text] [Related]
34. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier. Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473 [TBL] [Abstract][Full Text] [Related]
35. A New MicroRNA Expression Signature for Cervical Cancer. Sun P; Shen Y; Gong JM; Zhou LL; Sheng JH; Duan FJ Int J Gynecol Cancer; 2017 Feb; 27(2):339-343. PubMed ID: 27870701 [TBL] [Abstract][Full Text] [Related]
36. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease. Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437 [TBL] [Abstract][Full Text] [Related]
37. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer. You W; Wang Y; Zheng J Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838 [TBL] [Abstract][Full Text] [Related]
38. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. Nascimento NPG; Gally TB; Borges GF; Campos LCG; Kaneto CM BMC Cancer; 2022 Aug; 22(1):862. PubMed ID: 35933332 [TBL] [Abstract][Full Text] [Related]
40. Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis. Jiang Y; Hu Z; Zuo Z; Li Y; Pu F; Wang B; Tang Y; Guo Y; Tao H Biomed Res Int; 2020; 2020():4947381. PubMed ID: 32280688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]